1. van Woerden, Geeske M, Senden, Richelle, de Konink, Charlotte, Elgersma, Ype, Demirdas, Serwet. 2022. The MAP3K7 gene: Further delineation of clinical characteristics and genotype/phenotype correlations. In Human mutation, 43, 1377-1395. doi:10.1002/humu.24425. https://pubmed.ncbi.nlm.nih.gov/35730652/
2. Saxena, Vijay, Arregui, Samuel, Kamocka, Malgorzata Maria, Hains, David S, Schwaderer, Andrew. 2022. MAP3K7 is an innate immune regulatory gene with increased expression in human and murine kidney intercalated cells following uropathogenic Escherichia coli exposure. In Journal of cellular biochemistry, 123, 1817-1826. doi:10.1002/jcb.30318. https://pubmed.ncbi.nlm.nih.gov/35959632/
3. Shariq, Mohd, Quadir, Neha, Alam, Anwar, Hasnain, Seyed E, Ehtesham, Nasreen Z. 2022. The exploitation of host autophagy and ubiquitin machinery by Mycobacterium tuberculosis in shaping immune responses and host defense during infection. In Autophagy, 19, 3-23. doi:10.1080/15548627.2021.2021495. https://pubmed.ncbi.nlm.nih.gov/35000542/
4. Shariq, Mohd, Khan, Mohammad Firoz, Raj, Reshmi, Ahsan, Nuzhat, Kumar, Pramod. 2024. PRKAA2, MTOR, and TFEB in the regulation of lysosomal damage response and autophagy. In Journal of molecular medicine (Berlin, Germany), 102, 287-311. doi:10.1007/s00109-023-02411-7. https://pubmed.ncbi.nlm.nih.gov/38183492/
5. Jin, Xin, Ding, Donglin, Yan, Yuqian, Zhu, Runzhi, Huang, Haojie. 2018. Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression. In Molecular cell, 73, 22-35.e6. doi:10.1016/j.molcel.2018.10.034. https://pubmed.ncbi.nlm.nih.gov/30527665/
6. Cordas Dos Santos, David M, Eilers, Juliane, Sosa Vizcaino, Alfonso, Kulozik, Andreas E, Kunz, Joachim B. 2018. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB. In BMC cancer, 18, 663. doi:10.1186/s12885-018-4525-0. https://pubmed.ncbi.nlm.nih.gov/29914415/
智鼠故事 
